Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
- 30 April 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 18 (4) , 289-299
- https://doi.org/10.1016/0165-0327(90)90081-i
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Double-blind dose determination study of a new antidepressant?sertralineDrug Development Research, 1986
- FluvoxamineDrugs, 1986
- Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderlyBiological Psychiatry, 1986
- Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolitesEuropean Journal of Clinical Pharmacology, 1986
- Mianserin and Maprotiline as compared to Amitriptyline in Schevere Endogenous Depression. A New Methodological Approach to the Clinical Evaluation of the Efficacy of Antidepressants*Pharmacopsychiatry, 1982
- Dose-dependent kinetics of imipramine in elderly patientsPsychopharmacology, 1981
- The use of rating scales exemplified by a comparison of the Hamilton and the Bech‐Rafaelsen Melancholia ScaleActa Psychiatrica Scandinavica, 1980
- The WHO Depression Scale RELATIONSHIP TO THE NEWCASTLE SCALESActa Psychiatrica Scandinavica, 1980
- QUANTITATIVE RATING OF DEPRESSIVE STATESActa Psychiatrica Scandinavica, 1975
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965